Siga Technologies INC Unbilled Receivables, Current
Siga Technologies INC (SIGA) had Unbilled Receivables, Current of $200.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:UnbilledReceivablesCurrent · last filed 2025-11-06
- 2025-09-30: Unbilled Receivables, Current $200.00K.
- 2025-06-30: Unbilled Receivables, Current $700.00K.
- 2025-03-31: Unbilled Receivables, Current $900.00K.
- 2024-09-30: Unbilled Receivables, Current $2.80M.
| Period end | Unbilled Receivables, Current |
|---|---|
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $700.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $900.00K 10-Q · filed 2025-05-08 |
| 2024-09-30 | $2.80M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $8.70M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $16.80M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $6.90M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.80M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $5.10M 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |